A novel light therapy which combines infrared, red and violet light emitted through LEDs* appears safe and improves the conditions of finger ulcers in patients with systemic sclerosis (SSc), a pilot study shows.
It appears that early short-term nutritional intervention with 100-percent whey-based partially hydrolysed formula (PHF-W) instead of standard cow’s milk formula (CMF) lowers the incidence of atopic dermatitis (AD) and costs for healthy, high-risk, nonexclusively breastfed infants in Singapore, reports a study.
New drug applications approved by US FDA as of 16 - 31 August 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Superficial chemical peel treatments are safe for darker skins, yielding relatively low complication rates, a recent study has shown. However, those with skin type VI are at higher risk of adverse events.
Continuing treatment with oral propranolol beyond 6 months and up to 12 months appears to be effective in most patients with high-risk infantile hemangioma, producing meaningful increases in treatment success, a study has shown.
The causes, presentations and management of anaphylaxis vary considerably with age, according to a recent Singapore study, which reported that children are more likely to present with food anaphylaxis, while drug anaphylaxis is more common in adults.
Low-density lipoprotein cholesterol (LDL-C) levels remained high in many patients with stable or acute coronary heart disease (CHD) in Asia, despite having a very high risk of recurrent cardiovascular (CV) events, indicating that the use of lipid-lowering therapies and lipid monitoring were inadequate.
Substituting diets high in carbohydrates with those high in monounsaturated fatty acids in the context of low saturated fatty acids do not appear to yield favourable effects on blood pressure, according to a meta-analysis.